Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
The NO PAIN Act changes this policy by directing the Centers for Medicare and Medicaid Services to provide separate Medicare reimbursement for non-opioid treatments used to manage pain in both the hospital outpatient department and the ambulatory surgery center settings.
Pulsed Electromagnetic Fields for Postoperative Analgesia: A Randomized, Triple-Masked, Sham-Controlled Pilot Study
a study on Postoperative Pain Pain
Therefore, it has the potential to concurrently improve analgesia and decrease or even negate opioid requirements, only without the limitations of opioids and peripheral nerve blocks.
https://clinicaltrials.ucbraid.org/trial/NCT05399355
What is the Status of the NOPAIN Act? The NOPAIN Act was passed in an end-of-year legislative package in the 117th Congress in 2022. As a result of the law, patients and providers will have expanded access to non-opioids starting in 2025.
Amen Miamifl!!
Testing 1 2 3!
Go BIEL!
Extremity Trauma and Amputation Center of Excellence
The EACE leads the advancement of extremity trauma related discovery and clinical practice to optimize outcomes of service members, veterans, and beneficiaries while meeting the needs of the Combatant Commands and the Military Health System. The EACE is committed to ensuring a better future for those with extremity trauma. Established by the 2009 National Defense Authorization Act, the EACE is established jointly between the Department of Defense and the Department of Veterans Affairs.
The EACE was originally established to operate with the U.S. Army as its lead component. In October 2022 the EACE aligned to the Defense Health Agency in the Research & Engineering Directorate with the other Congressionally established Centers of Excellence.
https://health.mil/Military-Health-Topics/Centers-of-Excellence/EACE?type=Fact+Sheets
There she blows!
BioElectronics’ pulsed shortwave therapy device is effective for limb pain: study says
DEVICESNEUROLOGICAL
By NS Medical Staff Writer 26 Feb 2024
https://www.nsmedicaldevices.com/news/bioelectronics-pulsed-shortwave-therapy-device/
Someone’s a little bit sensitive!
Go Biel!
Your desperate!
Life is more than just money! Clearly your obsession with BIEL is unhealthy.
Put on an ActiPatch and see how it work on phantom brain.
Go BIEL!
Getting under your skin?
Lol!
Straight from the last update!
SALES
Company representatives attended the Modern Musculoskeletal Care Symposium this past weekend in Columbus, Ohio. We were once again invited to exhibit and Dr. Berend spoke to the medical professionals in attendance about “Non Thermal Pulsed Shortwave Therapy for Pre and Post Op Pain” Our attendance at the show was predicated on the expectation that the use of RecoveryRx will expand through the OrthoAlliance (https://orthoalliance.com/) organization in the next few months.
Thank you TeamBIEL!
Keep going you got this!!
The Recovery Pathway
Recovery Rx
A medical device that uses pulsed electromagnetic therapy to reduce pain and inflammation (not implanted).
https://orthoalliance.com/solutions-for-optimal-patient-outcomes/
Right on GG!
I’m a whale!
BioElectronics Corporation Announces the Publication of Pilot Study Results
Published: Feb 23, 2024
https://www.biospace.com/article/releases/bioelectronics-corporation-announces-the-publication-of-pilot-study-results/
Everything is working out nicely for BIEL.
BIEL is in whale watch mode…..
Don’t leave off the second clinical trial
It lost its brain… missing brain syndrome?
Clinical trial of one !
Did this PR get under your skin?
Lol!
The PR is out there for anyone to see…
Nope! Just getting started…IMO
Nope! Unlike you I’m not paid.
Antarctic blue whale
Go BIEL!
Moby-Dick!!
Go Biel!
EXECUTING OUR STRATEGY CONTINUED
OTC launched Bionase Nasal Spray, UTI-X and Actipatch musculoskeletal pain device.
https://adcock.co.za/documents/2023_Integrated_Report.pdf
Hope so!
Go BIEL!!
That’s too funny with the 911 last trade. It felt like it was going to happen.
Move over, bacon here comes Sizzlean!!